Pilot Study of Presurgical Tremelimumab With or Without Cryoablation in Patients With Metastatic Renal Cell Carcinoma (RCC)

Mise à jour : Il y a 4 ans
Référence : NCT02626130

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The goal of this clinical research study is to compare the safety and effectiveness of tremelimumab alone and in combination with cryoablation in patients with metastatic kidney cancer having surgery. Researchers also want to learn how the combination may affect the immune system. Cryoablation is a procedure that uses a hollow, thin tube called a cryoprobe to freeze and destroy cancer tissue.


Critère d'inclusion

  • Kidney Cancer

Liens